Fertility & conception

The ERA Test: Evidence Behind Receptivity Timing

Save

The ERA (endometrial receptivity analysis) times a frozen embryo transfer to your receptivity window using a lining biopsy during a mock cycle. For most people, randomized trials have not shown higher live birth rates than standard timing. It may still be considered after repeated failed transfers, but routine use is not supported.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

What is the ERA test?

The endometrial receptivity analysis, or ERA, is a test that samples the uterine lining during a mock cycle to estimate the window when the lining is most receptive to an embryo. The idea is that a small number of people have a shifted window, so timing a frozen embryo transfer to that personalized window might improve the odds.

A biopsy is taken, gene-expression patterns are read, and the result labels the lining receptive, pre-receptive, or post-receptive. Infertility is common — about 1 in 6 people, roughly 17.5%, experience it, according to the World Health Organization 1 — and the ERA is one of many add-on tests marketed to improve success. Whether it delivers on that promise is the real question.

What problem is the ERA trying to solve?

The ERA targets the window of implantation, the short span when the uterine lining can accept an embryo. In theory, a displaced window could explain why some good-quality embryos fail to implant.

Repeated implantation failure and pregnancy loss prompt a broader workup, and chromosomal and uterine factors are usually assessed first, according to the American Society for Reproductive Medicine 2. Age remains the dominant factor in outcomes: fertility declines gradually from around 32 and more steeply after 37, and miscarriage climbs from roughly 1 in 10 in the twenties to about 50% by the early forties 3. Against that backdrop, a shifted receptivity window is thought to affect only a minority of patients, which shapes how much the test can plausibly add.

Does the ERA test actually improve success?

For most people, high-quality randomized trials have not shown that ERA-guided timing improves live birth rates compared with standard transfer timing. The receptivity-window hypothesis is biologically reasonable, but when tested head-to-head, personalized timing has generally matched, not beaten, a standard protocol for unselected patients.

That gap between an appealing mechanism and disappointing trial results is common in fertility add-ons, which is why guidelines urge weighing the evidence rather than the marketing 4. Ovarian reserve tests and embryo genetics measure different things than endometrial timing 5, so a normal ERA does not offset other factors. None of this proves the test never helps — only that routine use has not improved outcomes for the average patient.

Who might still consider the ERA?

Some clinics still offer the ERA to people with repeated implantation failure despite transferring good embryos. The rationale is that if standard timing has failed more than once, identifying a displaced window might occasionally help, though even here the evidence is limited.

A workup for recurrent miscarriage or repeated failed transfers usually looks first at embryo genetics, the uterine cavity, and other treatable factors 2. Cost and an extra mock cycle are real trade-offs, since the biopsy requires a preparatory cycle before the actual transfer. A fertility evaluation weighs whether add-ons like the ERA fit your specific pattern or simply add time and expense 4.

When receptivity testing needs a fertility specialist

A fertility specialist can tell you whether an ERA fits your history or whether your time and money are better spent elsewhere. Because outcomes shift with age — success is highest in the late teens and twenties and declines through the thirties and into the perimenopausal years 3 — the value of any add-on depends on your stage and prior cycles.

Reasons to have this conversation include repeated failed transfers of good embryos, being offered the ERA without a clear rationale, or wanting an evidence-based second opinion. Comparing IVF success rates by age and reviewing your fertility evaluation can ground the choice. Gale can help you prepare questions before that visit.

Common questions

For most people, high-quality randomized trials have not shown higher live birth rates with ERA-guided timing than with standard timing. It may be considered in specific situations, such as repeated implantation failure, but routine use is not supported by current evidence. Your clinic can explain whether it fits your case.

A small biopsy of the uterine lining is taken during a mock cycle that mimics the hormones of a transfer cycle. Gene-expression patterns are analyzed, and the result labels the lining receptive, pre-receptive, or post-receptive. Because it needs a preparatory cycle, it adds time before the actual embryo transfer.

For the average patient, the evidence does not support routine use, so many people do not gain from it. The cost and an extra mock cycle are real trade-offs. It may be more reasonable to consider after repeated failed transfers, which is a decision to weigh with your fertility specialist.

It suggests the sampled lining had not yet reached its receptive window at the tested time point, implying the transfer might be timed a little later. Interpretation belongs with your clinic, since the result guides timing rather than giving a yes-or-no verdict on success.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Weighing an add-on test like the ERA

  • —Being offered the ERA or other add-ons without a clear, evidence-based rationale is a reason to ask for the supporting data or a second opinion.
  • —Repeated failed transfers of good-quality embryos are a reason to arrange a thorough fertility evaluation.
  • —Feeling pressured to pay for extra tests you do not understand is a reason to pause and seek independent advice.

This article is general health education, not medical advice. Whether the ERA test fits your situation is best decided with a reproductive endocrinologist who knows your cycle history.

References

  1. 1.World Health Organization (2025). Infertility (fact sheet). World Health Organization (WHO). link ✓Global infertility prevalence: about 1 in 6 people (roughly 17.5%) are affected, framing add-on tests within a common experience.
  2. 2.Practice Committee of the American Society for Reproductive Medicine (2026). Recurrent pregnancy loss: a committee opinion. Fertility and Sterility. doi:10.1016/j.fertnstert.2026.03.001 ✓Workup after repeated implantation failure or loss assesses embryo chromosomes, the uterine cavity, and other treatable factors first.
  3. 3.American College of Obstetricians and Gynecologists / American Society for Reproductive Medicine (2014). Female age-related fertility decline. Committee Opinion No. 589. Obstetrics & Gynecology. doi:10.1097/01.AOG.0000444440.96486.61 ✓Female age-related fertility decline: fertility declines gradually from around the early 30s and more steeply after the late 30s, with miscarriage rising from about 1 in 10 in the twenties toward roughly 50% by the early forties.
  4. 4.Practice Committee of the American Society for Reproductive Medicine (2021). Fertility evaluation of infertile women: a committee opinion. Fertility and Sterility. doi:10.1016/j.fertnstert.2021.08.038 ✓A structured fertility evaluation weighs whether add-on tests fit a patient's specific pattern, urging evidence over marketing.
  5. 5.Practice Committee of the American Society for Reproductive Medicine (2020). Testing and interpreting measures of ovarian reserve: a committee opinion. Fertility and Sterility. doi:10.1016/j.fertnstert.2020.09.134 ✓Ovarian reserve testing measures egg quantity, a different construct than endometrial receptivity timing.

5 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy

← Back to the health library